|
|
| | 2-Piperazineacetonitrile, 4-[7-(3-methoxy-1-naphthalenyl)-2-[[(2S)-1-methyl-2-pyrrolidinyl]methoxy]pyrido[2,3-d]pyrimidin-4-yl]-1-(1-oxo-2-propen-1-yl)-, (2S)- Basic information |
| | 2-Piperazineacetonitrile, 4-[7-(3-methoxy-1-naphthalenyl)-2-[[(2S)-1-methyl-2-pyrrolidinyl]methoxy]pyrido[2,3-d]pyrimidin-4-yl]-1-(1-oxo-2-propen-1-yl)-, (2S)- Chemical Properties |
| Boiling point | 820.2±75.0 °C(Predicted) | | density | 1.246±0.06 g/cm3(Predicted) | | pka | 9.17±0.40(Predicted) |
| | 2-Piperazineacetonitrile, 4-[7-(3-methoxy-1-naphthalenyl)-2-[[(2S)-1-methyl-2-pyrrolidinyl]methoxy]pyrido[2,3-d]pyrimidin-4-yl]-1-(1-oxo-2-propen-1-yl)-, (2S)- Usage And Synthesis |
| Uses | KRAS G12C inhibitor 43 (compound 59) is a potent KRAS G12C inhibitor. KRAS G12C inhibitor 43 shows antimigration and anti-proliferative activity with IC50s of 0.001-1 μM, >1 μM, >1 μM for H358, A549, HCC cells ,respectively[1]. | | IC 50 | KRas G12C | | References | [1] Xu Wei, et al. Pyridopyrimidine kras g12c mutant protein inhibitor. WO2021139678A1. |
| | 2-Piperazineacetonitrile, 4-[7-(3-methoxy-1-naphthalenyl)-2-[[(2S)-1-methyl-2-pyrrolidinyl]methoxy]pyrido[2,3-d]pyrimidin-4-yl]-1-(1-oxo-2-propen-1-yl)-, (2S)- Preparation Products And Raw materials |
|